76. Trump’s Tariffs Are Crippling MedTech - Here’s What Comes Next

In this week’s episode, Scott Addonizio gives a candid look at what it’s like to run a MedTech company when tariffs spike overnight. Disrupting supply chains, inflating costs, and forcing urgent business decisions.He shares how he navigated a 145% import tax on Chinese-made devices, protected customers from cost hikes, and why building U.S. manufacturing might be the only way forward. From OEM and ODM contracts to automation and global supply chain strain, Scott breaks down the pressure points companies are facing now, and what’s coming next.🎧 If you’ve ever wondered how MedTech companies actually respond when policy shifts overnight, or what it takes to protect your margins and keep moving, this one’s for you.00:00 Welcome back, Scott! 02:15 Tariff shock: what happened on “Liberation Day”04:12 How BrosMed absorbed costs instead of passing them on09:46 Why U.S. manufacturing is now on the table12:32 Making business decisions in a volatile political climate26:10 Best and worst-case scenarios for MedTech companies31:33 Why automation is the only viable way forward34:47 When the pain will show up: timeline for impact💡 Who Should ListenThis episode is for MedTech founders, device manufacturers, supply chain leads, and physicians working in outpatient settings who want a real look at global pressure on U.S. markets.About Scott AddonizioScott Addonizio is the Chief Operating Officer of BrosMed Medical, a global manufacturer of devices for vascular disease with a strong focus on lesion preparation. He also serves as President of BrosMed US, where he launched the company's executive and sales operations in Irvine, California.Previously, Scott was COO of MedAlliance, where he helped raise $50 million, led operations for the SELUTION drug-coated balloon, and secured four IDE approvals before the company was acquired by Cordis in 2024. He then served as Senior VP Operations at Cordis before moving to BrosMed.Scott is also acting COO at Solvein, a vein ablation start-up, and board member at Simpson Intervention, guiding sales strategy.Earlier in his career, he was COO and board director at OrbusNeich Medical, where he co-designed key devices like JADE, Sapphire, and Scoreflex Balloons, and held the primary patent for the “Stent Having Dual Helical Design.”He holds a B.S. in Packaging and Materials Engineering from Michigan State University and a Master’s in International Business from the University of Miami.Connect with Scott🌐 usa.brosmed.com💼 LinkedIn: Scott AddonizioFollow Life of Flow📲 Instagram: @LifeofFlowPodcast👍 Facebook: Life of Flow Podcast💼 LinkedIn: Life of Flow Podcast🐦 X: @VascularPodcastIf this one made you rethink how fast things can shift in MedTech, and what it actually takes to keep things moving, send it to a colleague who’s living it too. And if you’re getting value from these conversations, a quick review helps us keep them going!